Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

April 30, 2009

Conditions
InfluenzaOrthomyxovirus InfectionsMyxovirus Infection
Interventions
BIOLOGICAL

Inactivated, split-virion, influenza vaccine

0.1 mL, Intradermal

BIOLOGICAL

Inactivated, split-virion, influenza vaccine

0.5 mL, Intramuscular

BIOLOGICAL

Inactivated, split-virion influenza vaccine

0.1 mL, Intradermal

BIOLOGICAL

Inactivated, split-virion influenza vaccine

0.5 mL, Intramuscular

Trial Locations (1)

Unknown

Lyon Sud

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00776438 - Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines | Biotech Hunter | Biotech Hunter